Chemoinformaics analysis of (r)-dihydro-maleimide-beta-d-glucoside
| Molecular Weight | 261.23 | nRot | 3 |
| Heavy Atom Molecular Weight | 246.11 | nRig | 11 |
| Exact Molecular Weight | 261.085 | nRing | 2 |
| Solubility: LogS | -1.076 | nHRing | 2 |
| Solubility: LogP | -1.768 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 33.4159 |
| nHD | 5 | BPOL | 19.9581 |
| QED | 0.367 |
| Synth | 4.312 |
| Natural Product Likeliness | 1.917 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.185 |
| HIA | 0.76 |
| CACO-2 | -6.091 |
| MDCK | 0.000327485 |
| BBB | 0.731 |
| PPB | 0.153781 |
| VDSS | 0.625 |
| FU | 0.735296 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.046 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.274 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.27 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.013 |
| CL | 2.094 |
| T12 | 0.71 |
| hERG | 0.014 |
| Ames | 0.484 |
| ROA | 0.498 |
| SkinSen | 0.03 |
| Carcinogencity | 0.427 |
| EI | 0.024 |
| Respiratory | 0.1 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.765133 |